Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Immunosuppressive Treatment for Kidney Transplantation (CROSBI ID 179530)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Živčić-Ćosić, Stela ; Trobonjača, Zlatko ; Rački, Sanjin Immunosuppressive Treatment for Kidney Transplantation // Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki, XXXII (2011), 2; 87-103

Podaci o odgovornosti

Živčić-Ćosić, Stela ; Trobonjača, Zlatko ; Rački, Sanjin

engleski

Immunosuppressive Treatment for Kidney Transplantation

Immunosuppressive treatment minimizes unwanted immune reactivity, but it also leads to complications such as metabolic disorders, cardiovascular diseases and malignant tumors. In this paper we summarize the recent developments in action mechanisms of available immunosuppressive drugs and their usage for renal transplantation. These drugs act at various levels of lymphocytic activation and proliferation, and they may have additive or synergic effects when combined. In the majority of patients, the immunosuppressive protocol includes a calcineurin inhibitor (tacrolimus or cyclosporin), an antimetabolite (mycophenolate mofetil or mycophenolic acid) and a corticosteroid. Most patients also receive induction with monoclonal or polyclonal antilymphocytic antibodies. These immunosuppressive drugs allow a one-year survival of renal allografts in over 90% of cases and an incidence of acute rejection episodes below 15%. In most cases, acute cell-mediated rejection can be reversed with pulse doses of methylprednisolone ; less often antilymphocytic antibodies must be applied. Acute humoral rejection can be suppressed with high doses of intravenous immunoglobulines or low doses of cytomegalovirus hyperimmune globuline, in combination with plasmapheresis, to obtain a satisfactory reduction of anti-donor antibodies. This treatment also allows renal transplantation for sensitized recipients, or transplantation against a positive cross match or AB0 incompatibility. Less often, immunoadsorption, alemtuzumab, rituximab or splenectomy are applied. New immunosuppressive drugs and protocols are currently under investigation. Immunosuppressive agents and methods targeting at the induction of immune tolerance to the donor organ are especially promising.

Immunosuppression; Rejection; Renal transplantation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

XXXII (2)

2011.

87-103

objavljeno

0351-3254

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti

Poveznice
Indeksiranost